Top Markets
Coin of the day
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc.

BDSI
Classifica tra le azioni #16148
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical... BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.
Prezzo delle azioni
$5.59
Ultima sincronizzazione: 2022-03-31
Capitalizzazione di mercato
$310.83M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia BioDelivery Sciences International, Inc. (BDSI)

Categoria

Il prezzo BDSI con la capitalizzazione del mercato della B
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
BDSI
$5.59
Capitalizzazione di mercato di BioDelivery Sciences International, Inc.(BDSI)
Capitalizzazione di mercato: $310.83M
A partire dal September 2026, BioDelivery Sciences International, Inc. ha una capitalizzazione di mercato pari a $310.83M. Questo rende BioDelivery Sciences International, Inc. la 16148th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di BioDelivery Sciences International, Inc. dal 2002 al 2026
BDSI in paragone con la classifica dei più popolari stocks
Il prezzo per BDSI Attivo B Capitalizzazione del mercato a B Risultati
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$94,589.29 $310.83M
$5.260T +1,692,016.05%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$85,937.53 $310.83M
$4.779T +1,537,244.07%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$72,237.43 $310.83M
$4.017T +1,292,161.67%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$66,888.39 $310.83M
$3.719T +1,196,472.32%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$49,172.81 $310.83M
$2.734T +879,556.70%